The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNET

Rosaria Talarico; Silvia Aguilera; Tobias Alexander; Zahir Amoura; Ana M Antunes; Laurent Arnaud; Tadej Avcin; Lorenzo Beretta; Stefano Bombardieri; Gerd R Burmester; Sara Cannizzo; Lorenzo Cavagna; Benjamin Chaigne; Alain Cornet; Nathalie Costedoat-Chalumeau; Andrea Doria; Alessandro Ferraris; Rebecca Fischer-Betz; João E Fonseca; Charissa Frank; Andrea Gaglioti; Ilaria Galetti; Jürgen Grunert; Vera Guimarães; Eric Hachulla; Frederic Houssiau; Luca Iaccarino; Thomas Krieg; Marteen Limper; Fransiska Malfait; Xavier Mariette; Diana Marinello; Thierry Martin; Lisa Matthews; Marco Matucci-Cerinic; Alain Meyer; Carlomaurizio Montecucco; Luc Mouthon; Ulf Müller-Ladner; Simona Rednic; Vasco C Romão; Matthias Schneider; Vanessa Smith; Alberto Sulli; Farah Tamirou; Domenica Taruscio; Anna V Taulaigo; Enrique Terol; Angela Tincani; Jacob M van Laar

doi:10.1038/s41584-020-00565-z

The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNET

Rosaria Talarico, Silvia Aguilera, Tobias Alexander, Zahir Amoura, Ana M Antunes, Laurent Arnaud, Tadej Avcin, Lorenzo Beretta, Stefano Bombardieri, Gerd R Burmester, Sara Cannizzo, Lorenzo Cavagna, Benjamin Chaigne, Alain Cornet, Nathalie Costedoat-Chalumeau, Andrea Doria, Alessandro Ferraris, Rebecca Fischer-Betz, João E Fonseca, Charissa FrankAndrea Gaglioti, Ilaria Galetti, Jürgen Grunert, Vera Guimarães, Eric Hachulla, Frederic Houssiau, Luca Iaccarino, Thomas Krieg, Marteen Limper, Fransiska Malfait, Xavier Mariette, Diana Marinello, Thierry Martin, Lisa Matthews, Marco Matucci-Cerinic, Alain Meyer, Carlomaurizio Montecucco, Luc Mouthon, Ulf Müller-Ladner, Simona Rednic, Vasco C Romão, Matthias Schneider, Vanessa Smith, Alberto Sulli, Farah Tamirou, Domenica Taruscio, Anna V Taulaigo, Enrique Terol, Angela Tincani, Jacob M van Laar,

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

During the COVID-19 pandemic, the need to provide high-level care for a large number of patients with COVID-19 has affected resourcing for, and limited the routine care of, all other conditions. The impact of this health emergency is particularly relevant in the rare connective tissue diseases (rCTDs) communities, as discussed in this Perspective article by the multi-stakeholder European Reference Network on Rare and Complex Connective Tissue and Musculoskeletal Diseases (ERN ReCONNET). The clinical, organizational and health economic challenges faced by health-care providers, institutions, patients and their families during the SARS-CoV-2 outbreak have demonstrated the importance of ensuring continuity of care in the management of rCTDs, including adequate diagnostics and monitoring protocols, and highlighted the need for a structured emergency strategy. The vulnerability of patients with rCTDs needs to be taken into account when planning future health policies, in preparation for not only the post-COVID era, but also any possible new health emergencies.

Original language	English
Pages (from-to)	177-184
Number of pages	8
Journal	Nature Reviews. Rheumatology
Volume	17
Issue number	3
DOIs	https://doi.org/10.1038/s41584-020-00565-z
Publication status	Published - Mar 2021

Keywords

COVID-19/epidemiology
Comorbidity
Connective Tissue Diseases/epidemiology
Delivery of Health Care/organization & administration
Humans
Pandemics
SARS-CoV-2

Access to Document

10.1038/s41584-020-00565-z

Cite this

Talarico, R., Aguilera, S., Alexander, T., Amoura, Z., Antunes, A. M., Arnaud, L., Avcin, T., Beretta, L., Bombardieri, S., Burmester, G. R., Cannizzo, S., Cavagna, L., Chaigne, B., Cornet, A., Costedoat-Chalumeau, N., Doria, A., Ferraris, A., Fischer-Betz, R., Fonseca, J. E. (2021). The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNET. Nature Reviews. Rheumatology, 17(3), 177-184. https://doi.org/10.1038/s41584-020-00565-z

@article{57b855d73f8e4e938569296585c6f1b1,

title = "The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNET",

abstract = "During the COVID-19 pandemic, the need to provide high-level care for a large number of patients with COVID-19 has affected resourcing for, and limited the routine care of, all other conditions. The impact of this health emergency is particularly relevant in the rare connective tissue diseases (rCTDs) communities, as discussed in this Perspective article by the multi-stakeholder European Reference Network on Rare and Complex Connective Tissue and Musculoskeletal Diseases (ERN ReCONNET). The clinical, organizational and health economic challenges faced by health-care providers, institutions, patients and their families during the SARS-CoV-2 outbreak have demonstrated the importance of ensuring continuity of care in the management of rCTDs, including adequate diagnostics and monitoring protocols, and highlighted the need for a structured emergency strategy. The vulnerability of patients with rCTDs needs to be taken into account when planning future health policies, in preparation for not only the post-COVID era, but also any possible new health emergencies.",

keywords = "COVID-19/epidemiology, Comorbidity, Connective Tissue Diseases/epidemiology, Delivery of Health Care/organization & administration, Humans, Pandemics, SARS-CoV-2",

author = "Rosaria Talarico and Silvia Aguilera and Tobias Alexander and Zahir Amoura and Antunes, {Ana M} and Laurent Arnaud and Tadej Avcin and Lorenzo Beretta and Stefano Bombardieri and Burmester, {Gerd R} and Sara Cannizzo and Lorenzo Cavagna and Benjamin Chaigne and Alain Cornet and Nathalie Costedoat-Chalumeau and Andrea Doria and Alessandro Ferraris and Rebecca Fischer-Betz and Fonseca, {Jo{\~a}o E} and Charissa Frank and Andrea Gaglioti and Ilaria Galetti and J{\"u}rgen Grunert and Vera Guimar{\~a}es and Eric Hachulla and Frederic Houssiau and Luca Iaccarino and Thomas Krieg and Marteen Limper and Fransiska Malfait and Xavier Mariette and Diana Marinello and Thierry Martin and Lisa Matthews and Marco Matucci-Cerinic and Alain Meyer and Carlomaurizio Montecucco and Luc Mouthon and Ulf M{\"u}ller-Ladner and Simona Rednic and Rom{\~a}o, {Vasco C} and Matthias Schneider and Vanessa Smith and Alberto Sulli and Farah Tamirou and Domenica Taruscio and Taulaigo, {Anna V} and Enrique Terol and Angela Tincani and {van Laar}, {Jacob M}",

note = "Funding Information: This publication was funded by the European Union{\textquoteright}s Health Programme (2014–2020). Publisher Copyright: {\textcopyright} 2021, Springer Nature Limited.",

year = "2021",

month = mar,

doi = "10.1038/s41584-020-00565-z",

language = "English",

volume = "17",

pages = "177--184",

journal = "Nature Reviews. Rheumatology",

issn = "1759-4790",

publisher = "Nature Research",

number = "3",

}

Talarico, R, Aguilera, S, Alexander, T, Amoura, Z, Antunes, AM, Arnaud, L, Avcin, T, Beretta, L, Bombardieri, S, Burmester, GR, Cannizzo, S, Cavagna, L, Chaigne, B, Cornet, A, Costedoat-Chalumeau, N, Doria, A, Ferraris, A, Fischer-Betz, R, Fonseca, JE, Frank, C, Gaglioti, A, Galetti, I, Grunert, J, Guimarães, V, Hachulla, E, Houssiau, F, Iaccarino, L, Krieg, T, Limper, M, Malfait, F, Mariette, X, Marinello, D, Martin, T, Matthews, L, Matucci-Cerinic, M, Meyer, A, Montecucco, C, Mouthon, L, Müller-Ladner, U, Rednic, S, Romão, VC, Schneider, M, Smith, V, Sulli, A, Tamirou, F, Taruscio, D, Taulaigo, AV, Terol, E, Tincani, A, van Laar, JM 2021, 'The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNET', Nature Reviews. Rheumatology, vol. 17, no. 3, pp. 177-184. https://doi.org/10.1038/s41584-020-00565-z

TY - JOUR

T1 - The impact of COVID-19 on rare and complex connective tissue diseases

T2 - the experience of ERN ReCONNET

AU - Talarico, Rosaria

AU - Aguilera, Silvia

AU - Alexander, Tobias

AU - Amoura, Zahir

AU - Antunes, Ana M

AU - Arnaud, Laurent

AU - Avcin, Tadej

AU - Beretta, Lorenzo

AU - Bombardieri, Stefano

AU - Burmester, Gerd R

AU - Cannizzo, Sara

AU - Cavagna, Lorenzo

AU - Chaigne, Benjamin

AU - Cornet, Alain

AU - Costedoat-Chalumeau, Nathalie

AU - Doria, Andrea

AU - Ferraris, Alessandro

AU - Fischer-Betz, Rebecca

AU - Fonseca, João E

AU - Frank, Charissa

AU - Gaglioti, Andrea

AU - Galetti, Ilaria

AU - Grunert, Jürgen

AU - Guimarães, Vera

AU - Hachulla, Eric

AU - Houssiau, Frederic

AU - Iaccarino, Luca

AU - Krieg, Thomas

AU - Limper, Marteen

AU - Malfait, Fransiska

AU - Mariette, Xavier

AU - Marinello, Diana

AU - Martin, Thierry

AU - Matthews, Lisa

AU - Matucci-Cerinic, Marco

AU - Meyer, Alain

AU - Montecucco, Carlomaurizio

AU - Mouthon, Luc

AU - Müller-Ladner, Ulf

AU - Rednic, Simona

AU - Romão, Vasco C

AU - Schneider, Matthias

AU - Smith, Vanessa

AU - Sulli, Alberto

AU - Tamirou, Farah

AU - Taruscio, Domenica

AU - Taulaigo, Anna V

AU - Terol, Enrique

AU - Tincani, Angela

AU - van Laar, Jacob M

PY - 2021/3

Y1 - 2021/3

N2 - During the COVID-19 pandemic, the need to provide high-level care for a large number of patients with COVID-19 has affected resourcing for, and limited the routine care of, all other conditions. The impact of this health emergency is particularly relevant in the rare connective tissue diseases (rCTDs) communities, as discussed in this Perspective article by the multi-stakeholder European Reference Network on Rare and Complex Connective Tissue and Musculoskeletal Diseases (ERN ReCONNET). The clinical, organizational and health economic challenges faced by health-care providers, institutions, patients and their families during the SARS-CoV-2 outbreak have demonstrated the importance of ensuring continuity of care in the management of rCTDs, including adequate diagnostics and monitoring protocols, and highlighted the need for a structured emergency strategy. The vulnerability of patients with rCTDs needs to be taken into account when planning future health policies, in preparation for not only the post-COVID era, but also any possible new health emergencies.

AB - During the COVID-19 pandemic, the need to provide high-level care for a large number of patients with COVID-19 has affected resourcing for, and limited the routine care of, all other conditions. The impact of this health emergency is particularly relevant in the rare connective tissue diseases (rCTDs) communities, as discussed in this Perspective article by the multi-stakeholder European Reference Network on Rare and Complex Connective Tissue and Musculoskeletal Diseases (ERN ReCONNET). The clinical, organizational and health economic challenges faced by health-care providers, institutions, patients and their families during the SARS-CoV-2 outbreak have demonstrated the importance of ensuring continuity of care in the management of rCTDs, including adequate diagnostics and monitoring protocols, and highlighted the need for a structured emergency strategy. The vulnerability of patients with rCTDs needs to be taken into account when planning future health policies, in preparation for not only the post-COVID era, but also any possible new health emergencies.

KW - COVID-19/epidemiology

KW - Comorbidity

KW - Connective Tissue Diseases/epidemiology

KW - Delivery of Health Care/organization & administration

KW - Humans

KW - Pandemics

KW - SARS-CoV-2

UR - http://www.scopus.com/inward/record.url?scp=85099196317&partnerID=8YFLogxK

U2 - 10.1038/s41584-020-00565-z

DO - 10.1038/s41584-020-00565-z

M3 - Article

C2 - 33408338

SN - 1759-4790

VL - 17

SP - 177

EP - 184

JO - Nature Reviews. Rheumatology

JF - Nature Reviews. Rheumatology

IS - 3

ER -

The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNET

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this